MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-06-30, CRGX has $258,605K in assets. $20,908K in debts. $107,746K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1236.87%
Cash Ratio
515.33%
Debt to Asset Ratio
8.08%
Assets Breakdown
    • Short-term marketable securities
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued restructuring costs
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-06-30
Prepaid expenses and other current assets
4,992
Restricted cash
567
Short-term marketable securities
144,821
Cash and cash equivalents
107,746
Assets held for sale
479
Total current assets
258,605
Total assets
258,605
Operating lease liabilities, current
578
Accounts payable
8,668
Accrued restructuring costs
10,646
Accrued expenses and other current liabilities
739
Accrued clinical and research and development expenses
277
Total current liabilities
20,908
Operating lease liabilities, non-current
0
Total liabilities
20,908
Accumulated deficit
-447,083
Common stock
46
Additional paid-in capital
684,743
Accumulated other comprehensive income
-9
Total stockholders' equity
237,697
Total liabilities and stockholders' equity
258,605
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Assets held for sale$479K Cash and cashequivalents$107,746K Short-term marketablesecurities$144,821K Restricted cash$567K Prepaid expenses andother current assets$4,992K Total current assets$258,605K Total assets$258,605K Total liabilities andstockholders' equity$258,605K Total stockholders'equity$237,697K Total liabilities$20,908K Accumulated othercomprehensive income-$9K Accumulated deficit-$447,083K Additional paid-in capital$684,743K Total currentliabilities$20,908K Common stock$46K Accrued clinical andresearch and development...$277K Accrued expenses andother current...$739K Accrued restructuringcosts$10,646K Accounts payable$8,668K Operating leaseliabilities, current$578K

CARGO Therapeutics, Inc. (CRGX)

CARGO Therapeutics, Inc. (CRGX)